The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer

BJU International

Volumn 105, Issue 9, 2010, Pages 1237-1241

  Eisenberg, Michael L ^a   Cowan, Janet E ^a   Carroll, Peter R ^a   Shinohara, Katsuto ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Doppler colour ultrasonography; Prostatectomy; Prostatic neoplasms

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL EXAMINATION; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; DISEASE ACTIVITY; DISEASE FREE SURVIVAL; GRAY SCALE ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR LOCALIZATION;

EID: 77950834972     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08958.x     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96 (Pubitemid 351521864)
2. Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer 1997 79 : 528 537
3. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997 277 : 1445 1451
4. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005 23 : 8146 8151
5. Patel U, Rickards D. The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correlation. Br J Urol 1994 74 : 590 595 (Pubitemid 24348625)
6. Remzi M, Dobrovits M, Reissigl A et al. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol 2004 46 : 451 456 (Pubitemid 39200851)
7. Takahashi S, Yamada Y, Homma Y, Horie S, Hosaka Y, Kitamura T. Power Doppler ultrasonography-directed prostate biopsy in men with elevated serum PSA levels: an evaluation of the clinical utility and limitations. Urology 2002 60 : 248 252 (Pubitemid 34831767)
8. Colleselli D, Bektic J, Schaefer G et al. The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy. BJU Int 2007 100 : 1264 1267 (Pubitemid 350043913)
9. Mitterberger M, Pinggera G, Horninger W et al. Dutasteride prior to contrast-enhanced colour Doppler ultrasound prostate biopsy increases prostate cancer detection. Eur Urol 2008 53 : 112 117 (Pubitemid 350166703)
10. Inahara M, Suzuki H, Nakamachi H et al. Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer. Int Urol Nephrol 2004 36 : 175 180 (Pubitemid 38961767)
11. Shigeno K, Igawa M, Shiina H, Kishi H, Urakami S. Transrectal colour Doppler ultrasonography for quantifying angiogenesis in prostate cancer. BJU Int 2003 91 : 223 226 (Pubitemid 36232840)
12. Sauvain JL, Palascak P, Bourscheid D et al. Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol 2003 44 : 21 30 (Pubitemid 36741370)
13. Zalesky M, Urban M, Smerhovsky Z, Zachoval R, Lukes M, Heracek J. Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer. Int J Urol 2008 15 : 68 75
14. Eisenberg ML, Cowan JE, Davies BJ, Carroll PR, Shinohara K. The Importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol 2009 doi:10.1016/j.urolonc.2009.01.005
15. Augustin H, Graefen M, Palisaar J et al. Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging. J Clin Oncol 2003 21 : 2860 2868 (Pubitemid 46621834)
16. Ohori M, Kattan MW, Utsunomiya T, Suyama K, Scardino PT, Wheeler TM. Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible? J Urol 2003 169 : 964 968 (Pubitemid 36188135)
17. Kravchick S, Cytron S, Peled R, Ben-Dor D, Kravchenko Y. Colour Doppler ultrasonography for detecting perineural invasion (PNI) and the value of PNI in predicting final pathological stage: a prospective study of men with clinically localized prostate cancer. BJU Int 2003 92 : 28 31 (Pubitemid 36843023)
18. Cooperberg MR, Pasta DJ, Elkin EP et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005 173 : 1938 1942
19. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998 280 : 969 974 (Pubitemid 28445094)
20. Thompson IM, Tangen CM, Goodman PJ et al. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. J Urol 2007 177 : 1749 1752 (Pubitemid 46560657)
21. Lucia MS, Epstein JI, Goodman PJ et al. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2007 99 : 1375 1383 (Pubitemid 351767184)
22. Onur R, Littrup PJ, Pontes JE, Bianco FJ Jr. Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol 2004 172 : 512 514 (Pubitemid 38900192)
23. Purohit RS, Shinohara K, Meng MV, Carroll PR. Imaging clinically localized prostate cancer. Urol Clin North Am 2003 30 : 279 293 (Pubitemid 36520600)
24. Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ. Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997 158 : 2168 2175 (Pubitemid 27481351)
25. Eggener SE, Scardino PT, Carroll PR et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007 178 : 2260 7
26. Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 2009 104 : 195 199
27. Wallner PE, Konski A. The impact of technology on health care cost and policy development. Semin Radiat Oncol 2008 18 : 194 200 (Pubitemid 351718542)
28. Shinohara K, Wheeler TM, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 1989 142 : 76 82 (Pubitemid 19184007)
29. Ohori M, Egawa S, Shinohara K, Wheeler TM, Scardino PT. Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer. Br J Urol 1994 74 : 72 9 (Pubitemid 24221530)